Effect of ascorbic acid on tumour growth. by Migliozzi, J. A.
Br. J. Cancer (1977) 35, 448
EFFECT OF ASCORBIC ACID ON TUMOUR GROWTH
J. A. MIGLIOZZI
From the Department ofPathology, Peoria School of Medicine, University of Illinois,
Peoria, Illinois 61606, U.S.A.
Received 4 May 1976 Accepted 9 November 1976
Summary.-The growth of tumours in guinea-pigs was observed for 20 weeks
after placing them on various doses of vitamin C.
Complete tumour regression occurred in 55% of those animals receiving 0-3
mg/kg/day ascorbic acid, whereas animals given 10 mg/kg/day showed tumour
inhibition but no regression. In contrast, tumours in animals maintained on
1 g/kg/day ascorbic acid grew without sign of retardation. When increased amounts
of ascorbic acid were restored to the diet of scorbutic tumour-bearing animals,
tumours which had not regressed responded with enhanced growth. Likewise,
animals previously maintained on 10 mg/kg ascorbic acid responded in turn to the
additional vitamin with enhanced tumour growth. In contrast, all tumour-bearing
animals maintained on 1 g/kg ascorbic acid died within 3 weeks when this dose
was replaced with 0-3 mg/kg.
DESPITE the voluminous literature
which exists on vitamin C, few recent
studies are available concerning the effects
ofascorbic acid on the biology oftumours
More specifically, despite the current
interest in this vitamin, no adequate
studies are available demonstrating the
effects of prolonged ascorbic acid defi-
ciency on the neoplastic process. Except
for some earlier reports (Watson, 1936;
Robertson, Dalton and Heston, 1949;
Russell, Ortega and Wynne, 1952) on
guinea-pigs, most of the reports in the
literature refer to experiments in which
mice and rats were used (Pollia, 1935;
Woodhouse, 1934; Brunschwig, 1943).
The results of these latter experiments
are of questionable significance since the
animals were able to synthesize ascorbic
acid. The relationship ofdietary ascorbic
acid to cancer requires the use of an
animal incapable of synthesizing the
vitamin: viz., an inbred strain of guinea-
pigs. The major object of this study
is to determine whether vitamin C is
anecessaryrequirement fortumourgrowth
in guinea-pigs. In the present study,
we compared the effects of a mega-dose
of ascorbic acid and scorbutic amounts
on the growth of established tumours in
guinea-pigs.
MATERIALS AND METHODS
Eighty-five male guinea-pigs, Strain 2,
weighing 150-160 g were supplied by the
Fredericks Cancer Center, Frederick, Md.
The animals were housed in individual wire
cages and maintained on normal guinea-pig
chow and allowed free access to water.
After an acclimatization period of 2 weeks,
each animal was given a single 40-mg s.c.
injection of 20-methylehoanthrene. Of the
85 animals injected, 68 developed tumours
between 140 and 180 days. Histologically,
all tumours were of mesenchymal origin,
consisting of two or more mesenchymal
cell types. The most common were fibro-
sarcomata and liposarcomata. When the
tumours became palpable the animals were
divided into 3 groups, 20 animals/group,
according to tumour size. For this study
10 mg ascorbic acid/kg body weight was
chosen as the control diet. In another
group, the animals were fed a diet containing
0-3 mg ascorbic acid/kg to induce chronic
ascorbic aicd deficiency. The latter animals
were given supplemental ascorbic acid fromASCORBIC ACID AND TUMOUR GROWTH
time to time in order to prevent death from
scurvy. A third group received 1 g/kg
daily. After consuming these diets for
168 days, the doses were reversed so that
animals receiving 1 g were given 0 3 mg and
those previously given 10 mg and 0 3 mg
received 1 g ascorbic acid/kg. The vitamin
was given orally each day by dissolving the
required dose in water and depositing the
solution on the back of the tongue with
a 5-cm-long 16-gauge blunted needle. Guinea-
pig chow (Nutritional Biochem., Cleveland,
Ohio) containing no ascorbic acid was pro-
vided ad libitum, as was water. Tumour
size was calculated weekly from the two
diameters which lie in a plane parallel to
the body surface. Tumour biopsy speci-
mens were taken from a number of animals
in each group at 4-week intervals, processed
for histological examination and analysed
for total ascorbic acid. For histological
evaluation, the biopsy specimens were fixed
in formalin, embedded in paraffin, and
serially sectioned 8 ,tm thick. Slides were
stained with haematoxylin and eosin.
Blood was collected from some animals
in each group by jugular venepuncture and
analysed for total leucocyte ascorbic acid.
The blood was collected in a disposable
syringe and an aliquot transferred into tubes
containing 1 mg disodium-EDTA/ml of blood
and allowed to stand at room temperature
for 1 h. Leucocytes were separated accord-
ing to the procedure outlined by Skoog
and Beck (1956), using bovine fibrinogen.
Briefly, the procedure is as follows: ap-
proximately 2 ml of blood was added to
duplicate (20 x 150) mm test tubes each
containing 2 ml of a solution of 6% bovine
fibrinogen (Bovine Fibrinogen Fraction 1,
Nutritional Biochemical Corp., Cleveland,
Ohio) in 0-9% sodium chloride. The tubes
were mixed by inversion and allowed to
stand for 10 min. The top layers containing
leucocytes and platelets were removed by
aspiration, pooled and mixed, and a sample
counted with a haemocytometer. The vol-
ume of remaining leucocytes was recorded
after centrifuging at 1200 g for 15 min: the
clear supernatant was discarded. Approxi-
mately 1 ml of 2% metaphosphoric acid was
added to the precipitate, which was trans-
ferred to the vessel of a tissue grinder an
homogenized. After rinsing the vessels with
about 2 ml of 2% metaphosphoric acid the
homogenate was centrifuged at 1200 g for
10 min. The supernatant was collected and
assayed for total ascorbic acid on the same
day, according to the procedure of Zannoni
et al. (1974). Tumour biopsy specimens
were homogenized with 2% metaphosphoric
acid and assayed for total ascorbic in the
same manner.
RESULTS
High doses of ascorbic acid
As expected, higher amounts of as-
corbic acid (1 g/kg) were associated with
increased tumour growth (Fig. 1). De-
spite the size or mode of growth, certain
histological features were common to
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most tumours in animals given this
dose. The predominant picture was of
a highly malignant tumour consisting
of compactly arranged sarcoma cells
surrounded by a delicate stroma with the
staining characteristics of collagen (Fig.
2). Throughout, mitoses were frequent;
FIG. 2.-Tumours maintained on 1 g/kg
ascorbic acid for 20 weeks with compactly
arranged sarcoma cells surrounded by a
delicate stroma. x 60.
they were particularly abundant at the
periphery, where there was a tendency
in some cases to invade the surrounding
muscle and the connective tissue capsule.
All tumours had a seemingly well-de-
veloped blood supply, especially along
the periphery. Small central areas of
necrosis were seen, but this was not a
regular feature of these tumours. Of the
20 animals maintained on this diet,
5 died from the tumour by the 12th
week and another 6 died during the
next 8 weeks, so that by the 20th week
only 9 animals survived.
Low doses ofascorbic acid
Of the 20 animals maintained on a
scorbutic diet (0.3 mg/kg ascorbic acid),
16 showed marked inhibition of tumour
growth between the 4th and 8th weeks
(Fig. 1). Of these, 11 tumours regressed
completely by the 20th week. (Regres-
sion is defined in this study as one-half
the original tumour size.) Although there
was some difference in degrees of inhibi-
tion between the surviving animals, all
tumours maintained on this dose of
ascorbic acid reached a state between
the 4th and the 8th week when no further
increase in tumour size was noted.
The response to doses of 10 mg/kg
ascorbic acid was less uniform. On the
one hand, inhibition of tumour growth
was evident in 4 around the 4th week
and in 10 by the 12th week. After 16
weeks, the mean tumour size was 22 cm2,
and a further decrease was detected by
the 20th week. On the other hand,
tumour growth in 4 animals appeared
to be normal on a diet of 10 mg/kg.
Histology
Histologically, the inhibited tumours
were characterized by varying amounts
of haemorrhagic tissue extending from
the connective tissue capsule into the
tumour parenchyma (Fig. 3). There was
paucity of healthy tumour cells, with
less mitotic activity than in the growing
tumours. Small areas of lymphocytic
infiltration were occasionally found in
the inhibited tumours, but these were
also seen, to some degree, in some of the
growing tumours, and were not considered
an immune response.
It was not possible to distinguish
regressing tumours from inhibited tumours
until regression was well advanced. The
histological picture of regressing tumours
consisted almost entirely of haemor-
rhagic tissue, a slight amount fluid of
a viscous nature, cell degeneration and
varying amounts of necrosis. Within
the haemorrhagic tissue were numerous
wide spaces, some containing red cells
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FIG. 3.-Tumours maintained on 10 mg/kg FIG. 4.-Tumours maintained on 0 3 mg/kg
ascorbic acid for 20 weeks consisted mainly ascorbic acid for 20 weeks with wide spaces
ofhasmorrhagic connective tissue. x 60. containingred blood cells. The spaceswere
lined by a PAS-positive material. x 90.
surrounded by a PAS-staining material
(Fig. 4).
Effect on tumour growth of reversing the
diet
In order to distinguish the scorbutic
tumour changes after 24 weeks, the sur-
viving tumour-bearing animals maintain-
ed on an 0 3- and 10-mg/kg diet were
given mega doses (1 g/kg) of vitamin C,
while animals previously maintained on
high levels were given scorbutic doses
of 0 3 mg/kg. In the latter group, all
the animals became lethargic and died
within 3 weeks. At autopsy, these ani-
mals demonstrated many of the changes
characteristic of scurvy. These included
oedema, haemorrhage, ulcerated gastric
mucosa and enlarged viscera. The area
surrounding the tumour was oedematous
and filled with slightly viscous fluid.
At autopsy, most tumours in this group
had invaded the dermis and surrounding
muscle. Histologically, the bulk con-
sisted of seemingly healthy tumour with
varying amounts of necrotic and haemor-
rhagic tissue.
Only 2 animals previously maintained
on scorbutic doses of 0 3 mg, and 3
animals on 10 mg ascorbic acid responded
with enhanced tumour growth when 1 g
ascorbic acid/kg was given. These tu-
mours, although previously inhibited, had
not regressed at the time the diets were
changed at 20 weeks.
Ascorbic acid content
The total ascorbic acid concentrations
in leucocytes and tumours are shown in
the Table. Results are as expected.
In animals given 1 g ascorbic acid/kg
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TABLE. Ascorbic Acid in Leucocytes and Turnours
Leucocyte: ,ug ascorbic acid/l0 cells
Tuimour: mg ascorbic acid/100 g
Week
4
8
12
16
20
24
4
8
12
16
20
24
Ascorbic acid dose (mg/kg/day)
0 3 10 1000
3-8 1-5* 5-8±2-3 24-2± 6-6
2-4±1-6 4-6±1-9 32-1+10-3
1-7±0-9 4-1±2-7 29-1± 9-2
1-2±0-8 2-9±2-1 35-8±15-4
2-2±1-4t 4-6±1-7 23-3± 6-4
21-8±7-8 16-3±4-7 11-5± 8-4
2-3±1-9 9-9±2-3
1-2±0-4 4-7±2-9
3 9±2 9
8 -1±3-4
6-7±2 0
14-8±3-6
22-8± 6-8
36 9± 8-7
33-7± 9-6
41-9± 9 7
50 -9± 18 -4
24 - 3± 11 -2
* The numbers reflect, the mean X the standard cleviation of 8 observations.
t After 20 weeks on diets of 0 3 mg and 10 mg ascorbic acid/kg these animals were st,arted on diets
containing 1 g/kg.
t Animals previously maintained on diets with 1 g/kg of ascorbic acid were given 0 3 mg/kg on Week 20.
Insufficient tumour tissue was available for vitamin analysis.
N.B. The vitamin contents of leucocytes and t,umour tissue are in different units.
daily, the amount of ascorbic acid in
leucocytes dropped rapidly when these
animals were deprived of the vitamin,
but the tumour levels remained high.
DISCUSSION
The present data suggest that ascorbic
acid is an indispensable requirement for
tumour growth.
Maintaining tumour-bearing guinea-
pigs on a low vitamin C diet favours
immediate growth inhibition. The histo-
logical data reveal that in the vitamin-
depleted animals the main effect within
the tumour was the destruction of blood
vessels and interstitial stroma, with the
spread of haemorrhagic tissue deep into
the tumour parenchyma. Although the
initial event in this case appears to be
related to the destruction of collagen,
we are inclined to believe that some other
biochemical or immunological event is
involved. This belief is based on two
experimental findings. Firstly, in the
vitamin-C-depleted animals withregressing
tumour, destruction of connective tissue
occurred first within the tumour, inde-
pendent of any widespread destruction
in the host. This occurred despite low
levels of ascorbic acid in all tissues of
the body, as reflected by the leucocyte
ascorbic acid levels. Secondly, the peri-
pheral lymphocyte count was not de-
pressed in scorbutic animals, suggesting
that these cells might be of assistance to
the deficient animal in eliminating the
inhibited tumour. In this regard, in-
volvement of ascorbic acid in the immune
response is poorly understood. Experi-
mental evidence indicates that vitamin C
reduces the immunological response (Ku-
mar and Axelrod, 1969; Kies, Mueller
and Alvord, 1964; Kalden and Guthy,
1972). Further studies on lymphocytes
and their subpopulations, associated with
vitamin C deficiency and tumour growth,
are under way in our laboratory.
In our study the stimulation oftumour
growth by megadoses of vitamin C
agrees with earlier reports (Brunschwig,
1943; Fodor and Kunos, 1934; Watson,
1936). It might be expected that rapidly
growing tumour tissue would have a
greater requirement than most adult
tissue for ascorbic acid. That the tumour
is dependent on vitamin C for growth is
further evidenced by the response seen
after reversing the diet. All tumour-
bearing animals previously maintained
on 1 g ascorbic acid died within 21 days
when given 03 mg/kg, suggesting that
the host could not compete with the
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tumour for the vitamin under this condi-
tion. Gordonoff (1960) reported that
guinea-pigs maintained on a diet con-
taining 500 mg ascorbic acid/100 g daily
for 4 weeks developed scurvy more
rapidly than normally fed control animals,
when ascorbic acid was withheld from
the diet. Likewise, observations in man
(Schrauzer and Rhead, 1973) suggest
that high intakes induce an increased
requirement for the vitamin.
One objective of this experiment was
to evaluate the ascorbic acid requirement
for tumour growth. The results indicate
that ascorbic acid is necessary for tumour
growth in the system studied.
The cost of this investigation was
supported by a General Research Support
Grant from the University of Illinois
College of Medicine, Chicago.
REFERENCES
BRi-NSCHwI(G,, A. (1943) Vitamin C an(I Tumor
Growth. (ancer Res., 3, 550.
FoDoR, E. & KuNOS, S. (1934) Die Wirkung der
reinen Ascorbinsaure (Vitamin-C) auf das Wach-
sttum des experimentellen Mijusecarcinoms. Krebs-
forsch., 40, 566.
GORDONOFF, F. (1960) Should One Give Excess
Water-soluble Vitamins? Experiments with Vita-
mini C. Schweiz. med. 'schr., 90, 726.
KALDEN, J. R. & GUtTHY, E. A. (1972) Proloinged
Skin Allograft Survival in Vitamin C-deficient
Guinea-pigs. Eur. Surg. Res., 4, 114.
KIES, M. W., MUELLER, S. & ALVORD, E. C., JR.
(1964) Influence of Ascorbic Acid Deficiency
on Immunologic Mechanisms. Z. Immun. Al-
lergie For8ch., 126, 228.
KIMAR, M. & AxELROD, A. E. (1969) Circulating
Antibody Formation in Scorbutic Guinea Pigs.
J. Nutr., 98, 41.
POLLIA, J. A. (1935) Observations on Rats Treated
with Cevitamic (Ascorbic) Acidl. Radiology, 25,
338.
ROBERTSON, W. VAN B., DALTON, A. J. & HESTON,
W. E. (1949) Changes in a Transplaintedt Fibro-
sarcoma Associated with Ascorbic Acid Defi-
ciency. .J. natn. Cancer Inst., 10, 53.
RUSSELL, W. O., ORTEGA, L. R. & WYNNE, E. S.
(1952) Stucies on Methylcholanthrene Indluction
of Tumors in Scorbutic Guinea Pigs. Caincer
Res., 12, 216.
SCHRAUZER, G. N. & RHEAD, W. J. (1973) Ascorbic
Acid Abuse: Effect of Long Term Ingestion of
Excessive Amounts on Blood Levels and Urinary
Excretion. Int. J. Vit. Nutr. Res., 43, 201.
SKOOG, W. A. & BECK, W. S. (1956) Studies on the
Fibrinogen, Dextran and PHA MIethods of
Isolating Leukocytes. Blood, 11, 436.
WATSON, A. F. (1936) The Chemical Reducing
Capacity and Vitamin C Content ofTransplantable
Tumors of the Rat and Guinea Pig. Br. J. exp.
Path., 17, 124.
WOODHOISE, D. L. (1934) Action of Ascorbic
Acid on Tumor Metabolism; A Preliminary
Note on the Effects Observed Following Injection
into Mice with Tar-induced Neoplasms. Bio-
chem. J., 28, 1974.
ZANNONI, V., LYNCH, M., GOLDSTEIN, S. & SATO, P.
(1974) A Rapid Micromethod for the Determina-
tion of Ascorbic Acid in Plasma and Tissues.
Biochem. Med., 11, 41.